Hiroki Torikai

1.8k total citations
32 papers, 1.4k citations indexed

About

Hiroki Torikai is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Hiroki Torikai has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Oncology and 13 papers in Molecular Biology. Recurrent topics in Hiroki Torikai's work include T-cell and B-cell Immunology (14 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (12 papers). Hiroki Torikai is often cited by papers focused on T-cell and B-cell Immunology (14 papers), CAR-T cell therapy research (13 papers) and Immunotherapy and Immune Responses (12 papers). Hiroki Torikai collaborates with scholars based in United States, Japan and Italy. Hiroki Torikai's co-authors include Laurence J.N. Cooper, Helen Huls, Richard E. Champlin, Dean A. Lee, Partow Kebriaei, Michael C. Holmes, Edward J. Rebar, Andreas Reik, Philip D. Gregory and Yuanyue Zhou and has published in prestigious journals such as Journal of Clinical Investigation, Blood and The Journal of Immunology.

In The Last Decade

Hiroki Torikai

32 papers receiving 1.4k citations

Peers

Hiroki Torikai
Tea Gogishvili Germany
Rayne H. Rouce United States
Dimitrios L. Wagner Germany
Yuriko Fujita Japan
Maria‐Luisa Schubert Germany
Peihua Lu China
Virna Marin Italy
Kevin G. Pinz United States
Jessica Hartmann Germany
Maksim Mamonkin United States
Tea Gogishvili Germany
Hiroki Torikai
Citations per year, relative to Hiroki Torikai Hiroki Torikai (= 1×) peers Tea Gogishvili

Countries citing papers authored by Hiroki Torikai

Since Specialization
Citations

This map shows the geographic impact of Hiroki Torikai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Torikai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Torikai more than expected).

Fields of papers citing papers by Hiroki Torikai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroki Torikai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Torikai. The network helps show where Hiroki Torikai may publish in the future.

Co-authorship network of co-authors of Hiroki Torikai

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Torikai. A scholar is included among the top collaborators of Hiroki Torikai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Torikai. Hiroki Torikai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Torikai, Hiroki, Tiejuan Mi, Loren Gragert, et al.. (2016). Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application. Scientific Reports. 6(1). 21757–21757. 38 indexed citations
2.
Weng, Jinsheng, Hiroki Torikai, Hua Wang, et al.. (2016). Targeting B-cell malignancies through human B-cell receptor specific CD4+T cells. OncoImmunology. 5(11). e1232220–e1232220. 3 indexed citations
3.
Thokala, Radhika, Simon Olivares, Tiejuan Mi, et al.. (2016). Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors. PLoS ONE. 11(8). e0159477–e0159477. 51 indexed citations
4.
Tian, Gengwen, Amy N. Courtney, Bipulendu Jena, et al.. (2016). CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. Journal of Clinical Investigation. 126(6). 2341–2355. 133 indexed citations
5.
Caruso, Hillary G., Hiroki Torikai, Ling Zhang, et al.. (2016). Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor. Journal of Immunotherapy. 39(5). 205–217. 30 indexed citations
6.
Torikai, Hiroki & Laurence J.N. Cooper. (2016). Translational Implications for Off-the-shelf Immune Cells Expressing Chimeric Antigen Receptors. Molecular Therapy. 24(7). 1178–1186. 54 indexed citations
7.
Maiti, Sourindra N., Helen Huls, Harjeet Singh, et al.. (2013). Sleeping Beauty System to Redirect T-cell Specificity for Human Applications. Journal of Immunotherapy. 36(2). 112–123. 67 indexed citations
8.
Bleakley, Marie, Aiko Sato‐Otsubo, Hiroki Torikai, et al.. (2012). HapMap SNP Scanner: an online program to mine SNPs responsible for cell phenotype. Tissue Antigens. 80(2). 119–125. 4 indexed citations
9.
Torikai, Hiroki, Andreas Reik, Yuanyue Zhou, et al.. (2012). A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR. Blood. 119(24). 5697–5705. 417 indexed citations
10.
Demachi‐Okamura, Ayako, Hiroki Torikai, Yoshiki Akatsuka, et al.. (2012). Autophagy Creates a CTL Epitope That Mimics Tumor-Associated Antigens. PLoS ONE. 7(10). e47126–e47126. 14 indexed citations
11.
Torikai, Hiroki, Nobuhiko Imahashi, Ayako Demachi‐Okamura, et al.. (2011). Mismatched human leukocyte antigen class II‐restricted CD8+ cytotoxic T cells may mediate selective graft‐versus‐leukemia effects following allogeneic hematopoietic cell transplantation. Cancer Science. 102(7). 1281–1286. 4 indexed citations
12.
Choi, Yoonsu, Carrie Yuen, Sourindra N. Maiti, et al.. (2010). A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells. Biomedical Microdevices. 12(5). 855–863. 23 indexed citations
13.
Kobayashi, Susumu, Fumihiko Kimura, Takashi Ikeda, et al.. (2009). BCR–ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression. Leukemia. 23(9). 1622–1627. 13 indexed citations
14.
Kawase, Takakazu, Yasuhito Nannya, Hiroki Torikai, et al.. (2008). Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood. 111(6). 3286–3294. 40 indexed citations
15.
Torikai, Hiroki, Yoshiki Akatsuka, Seitaro Terakura, et al.. (2007). The HLA-A*0201-restricted minor histocompatibility antigen HA-1H peptide can also be presented by another HLA-A2 subtype, A*0206. Bone Marrow Transplantation. 40(2). 165–174. 21 indexed citations
16.
Kobayashi, Shinichi, Fumihiko Kimura, Yukihiro Hama, et al.. (2007). Histiocytic sarcoma of the spleen: case report of asymptomatic onset of thrombocytopenia and complex imaging features. International Journal of Hematology. 87(1). 83–87. 19 indexed citations
17.
Morishima, Satoko, Yoshiki Akatsuka, Akihiro Nawa, et al.. (2006). Identification of an HLA‐A24‐restricted cytotoxic T lymphocyte epitope from human papillomavirus type‐16 E6: The combined effects of bortezomib and interferon‐γ on the presentation of a cryptic epitope. International Journal of Cancer. 120(3). 594–604. 22 indexed citations
18.
Kimura, Fumihiko, Ken Sato, Shinichi Kobayashi, et al.. (2006). Impacts of ABO-Blood Type Incompatibility on Outcome of Unrelated Bone Marrow Transplantation through the Japan Marrow Donor Program.. Blood. 108(11). 173–173. 1 indexed citations
19.
Torikai, Hiroki, Yoshiki Akatsuka, Mikinori Miyazaki, et al.. (2006). The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA‐A*3101 and ‐A*3303. British Journal of Haematology. 134(4). 406–416. 24 indexed citations
20.
Kimura, Fumihiko, Shinichi Kobayashi, Hiroki Torikai, et al.. (2005). Myeloid/NK cell precursor acute leukemia lost both CD13 and CD33 at first diagnosis. Leukemia Research. 30(6). 761–763. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tea Gogishvili Breakdown of academic impact, for papers by Rayne H. Rouce Breakdown of academic impact, for papers by Dimitrios L. Wagner Breakdown of academic impact, for papers by Yuriko Fujita Breakdown of academic impact, for papers by Maria‐Luisa Schubert Breakdown of academic impact, for papers by Peihua Lu Breakdown of academic impact, for papers by Virna Marin Breakdown of academic impact, for papers by Kevin G. Pinz Breakdown of academic impact, for papers by Jessica Hartmann Breakdown of academic impact, for papers by Maksim Mamonkin
Rankless by CCL
2026